Clinical Trials Browser

INDUSTRY × Small Cell Lung Carcinoma × fluzoparib × Clear all

NCT04400188 2025-06-29

A Study of Fluzoparib (SHR-3162) and Temozolomide With or Without SHR-1316 in Treating Patients With Replapsed Small Cell Lung Cancer

Phase 1/2 Completed

Small Cell Lung Carcinoma